Interferon-gamma and host antimicrobial defense: Current and future clinical applications
- 1 November 1994
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 97 (5) , 459-467
- https://doi.org/10.1016/0002-9343(94)90326-3
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (Al-16963)
This publication has 64 references indexed in Scilit:
- Short term treatment of visceral leishmaniasis of the old world with low dose interferon gamma and pentavalent antimonyInfection, 1993
- Immune Response in Mice that Lack the Interferon-γ ReceptorScience, 1993
- Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ GenesScience, 1993
- Regulation of Immunity to Parasites by T Cells and T Cell-Derived CytokinesAnnual Review of Immunology, 1992
- Role of gamma interferon inToxoplasma gondii infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense in vitro, in animal models, and in humansDiagnostic Microbiology and Infectious Disease, 1990
- Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon GammaNew England Journal of Medicine, 1988
- Immunochemotherapy for Intracellular Leishmania donovani Infection: Interferon Plus Pentavalent AntimonyThe Journal of Infectious Diseases, 1988
- EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERONPublished by Elsevier ,1987
- Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous LeprosyNew England Journal of Medicine, 1986